Xiaodong Wang

发表

Pharmacokinetic Interactions of Rolapitant With Cytochrome P450 3A Substrates in Healthy Subjects

J. Christensen, Zhi-yi Zhang, L. Hughes, 2018, Journal of clinical pharmacology.

Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study

H. Xiang, Yan Yan, Wenhong Zhang, 2021, Clinical Gastroenterology and Hepatology.

Population Pharmacokinetics of Rolapitant in Patients With Chemotherapy‐Induced Nausea and Vomiting

Zhi-yi Zhang, V. Kansra, Xiaodong Wang, 2019, Clinical pharmacology in drug development.

Pharmacokinetics of Rolapitant in Patients With Mild to Moderate Hepatic Impairment

Zhi-yi Zhang, V. Kansra, Xiaodong Wang, 2018, Journal of clinical pharmacology.

Effects of rolapitant administered orally on the pharmacokinetics of dextromethorphan (CYP2D6), tolbutamide (CYP2C9), omeprazole (CYP2C19), efavirenz (CYP2B6), and repaglinide (CYP2C8) in healthy subjects

Zhi-yi Zhang, V. Kansra, Xiaodong Wang, 2018, Supportive Care in Cancer.

Derivation of Phase 3 dosing for peginterferon lambda‐1a in chronic hepatitis C, Part 2: Exposure–response analyses for efficacy and safety variables

V. Kansra, J. Freeman, Xiaodong Wang, 2015, Journal of clinical pharmacology.

Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection.

P. Marcellin, P. Thuluvath, G. Everson, 2014, Gastroenterology.

Derivation of Phase 3 dosing for peginterferon lambda‐1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response rates

V. Kansra, J. Freeman, Xiaodong Wang, 2015, Journal of clinical pharmacology.

Pharmacokinetics, Safety, and Tolerability of Rolapitant Administered Intravenously Following Single Ascending and Multiple Ascending Doses in Healthy Subjects

Zhi-yi Zhang, V. Kansra, Xiaodong Wang, 2018, Clinical pharmacology in drug development.

Early antiviral therapy of abidor combined with lopinavir/ritonavir and re-combinant interferonα-2b in patients with novel coronavirus pneumonia in Zhejiang: A multicenter and prospective study/ 中华临床感染病杂志

Lanjuan Li, Shibo Li, Kaijin Xu, 2020 .

Bioequivalence of Intravenous and Oral Rolapitant: Results From a Randomized, Open‐Label Pivotal Study

J. Christensen, Zhi-yi Zhang, L. Hughes, 2017, Journal of clinical pharmacology.

Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study

H. Xiang, Xianghui Qi, Jing-wen Ai, 2022, Hepatology International.

Effectiveness and Tolerability of Micafungin in Chinese Patients with Invasive Fungal Infections: A Retrospective, Multicenter Study

Wei Li, Jianda Hu, Jianfeng Zhou, 2018, Advances in Therapy.

Neoadjuvant pyrotinib plus trastuzumab and nab-paclitaxel for HER2-positive early or locally advanced breast cancer: an exploratory phase II trial.

Q. Lv, Xiaodong Wang, Jing Wang, 2022, Gland surgery.

Absorption, metabolism, and excretion of the antiemetic rolapitant, a selective neurokinin-1 receptor antagonist, in healthy male subjects

Zhi-yi Zhang, V. Kansra, Xiaodong Wang, 2018, Investigational new drugs.

Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions

Xiaodong Wang, Qian Chen, Chen Yu, 2020, Drug design, development and therapy.

Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions

Xiaodong Wang, Qian Chen, Chen Yu, 2020 .

Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients.

P. Tebas, M. Boffito, R. Bertz, 2011, AIDS patient care and STDs.

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

W. Xu, Weili Zhao, P. Liu, 2017, Journal of Hematology & Oncology.

Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial Tumors

A. Jimeno, M. Hidalgo, J. Baselga, 2015, Clinical Cancer Research.

Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5‐fluorouracil or carboplatin/paclitaxel for first‐line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck

A. Jimeno, J. Machiels, T. Seiwert, 2016, Cancer.

An Open‐Label, Randomized, Pivotal Bioequivalence Study of Oral Rolapitant

Zhi-yi Zhang, V. Kansra, Xiaodong Wang, 2019, Clinical pharmacology in drug development.

Effects of Rolapitant Administered Intravenously on the Pharmacokinetics of a Modified Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan) in Healthy Subjects

Zhi-yi Zhang, V. Kansra, Xiaodong Wang, 2018, Journal of clinical pharmacology.

Characterization of a new class of selective nonsteroidal progesterone receptor agonists

J. Y. Roberge, D. Schnur, R. Seethala, 2004, Steroids.

Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Baoding, Hebei province, China

Penghui Shi, Xiaodong Wang, Weiguang Fan, 2022, Frontiers in Genetics.

Safety and immunogenicity of COVID‐19 vaccination in patients with hepatocellular carcinoma (CHESS‐NMCID 2101): A multicenter prospective study

H. Xiang, Xianghui Qi, Chuan Liu, 2022, Journal of medical virology.

A Phase 1 Assessment of the QT Interval in Healthy Adults Following Exposure to Rolapitant, a Cancer Supportive Care Antiemetic

Zhi-yi Zhang, V. Kansra, Xiaodong Wang, 2018, Clinical pharmacology in drug development.

Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P‐glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers

J. Christensen, Zhi-yi Zhang, L. Hughes, 2018, Journal of clinical pharmacology.

Prevention and treatment of new hepatitis B after living donor liver transplantation in children

Xiaodong Wang, Junjie Li, Ming Ma, 2021, Translational pediatrics.

Long-Term Safety and Efficacy Data of Golodirsen in Ambulatory Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A First-in-human, Multicenter, Two-Part, Open-Label, Phase 1/2 Trial

E. Mercuri, F. Muntoni, L. Servais, 2021, Nucleic acid therapeutics.

A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of Obexelimab in Systemic Lupus Erythematosus with Exploration of Response Based on Gene Pathway Co-Expression Patterns.

J. Guthridge, J. Merrill, J. James, 2023, Arthritis & rheumatology.